InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Reilly Thomas Charles, Chief Financial Officer. Officer active across 2 companies, notably Cara Therapeutics, Inc.. In total, 11 filings have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €45k. Activity tracked since 24 August 2021. The latest transaction was disclosed on 3 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Reilly Thomas Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
16,667 sharesOrdinary SharesSEC:0000950170-24-079717:0
33,333 sharesOrdinary SharesSEC:0000950170-24-076300:0
44,933 sharesOrdinary SharesSEC:0000950170-24-010534:0
51,500 sharesOrdinary SharesSEC:0000950170-24-004305:0
16,667 sharesOrdinary SharesSEC:0000899243-23-016904:0
33,334 sharesOrdinary SharesSEC:0000899243-23-016257:0
2,044 shares@ US$11.3846.7% of flowCommon StockSEC:0001209191-22-016438:0
20,000 shares0Common StockSEC:0001209191-22-013992:0
11,170 shares0Common StockSEC:0001209191-21-070801:0
1,982 shares@ US$14.2053.3% of flowCommon StockSEC:0001209191-21-054303:0
5,334 shares0Common StockSEC:0001209191-21-053538:0
11 of 11 declarations
About Reilly Thomas Charles
Reilly Thomas Charles is Directeur Financier and has filed 11 filings in total. In the recent filings available, they cover the period from 2021-08-26 to 2024-07-01, with EUR 44790 of sales and no purchases. The companies listed are Amarin CORP Plc\uk, where he is EVP and CFO, and Cara Therapeutics, Inc., where he is Chief Financial Officer.
